CHAMPIONS ONCOLOGY, INC. Quarterly Operating Margin in % from Q1 2020 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Champions Oncology, Inc. quarterly/annual Operating Margin history and growth rate from Q1 2020 to Q4 2024.
  • Champions Oncology, Inc. Operating Margin for the quarter ending January 31, 2025 was 10.7 %.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 10.7 +30.2 Nov 1, 2024 Jan 31, 2025
Q3 2024 -1.47 +17.5 +92.3% Aug 1, 2024 Oct 31, 2024
Q2 2024 -6.73 +7.55 +52.9% May 1, 2024 Jul 31, 2024
Q1 2024 -14.7 -4.91 -50.3% Feb 1, 2024 Apr 30, 2024
Q4 2023 -19.5 -13.8 -244% Nov 1, 2023 Jan 31, 2024
Q3 2023 -19 -19.4 -4343% Aug 1, 2023 Oct 31, 2023
Q2 2023 -14.3 -15.3 -1580% May 1, 2023 Jul 31, 2023
Q1 2023 -9.76 -11 -889% Feb 1, 2023 Apr 30, 2023
Q4 2022 -5.67 -6.25 -1079% Nov 1, 2022 Jan 31, 2023
Q3 2022 0.45 -0.51 -53.6% Aug 1, 2022 Oct 31, 2022
Q2 2022 0.97 +0.57 +146% May 1, 2022 Jul 31, 2022
Q1 2022 1.24 +0.34 +38.1% Feb 1, 2022 Apr 30, 2022
Q4 2021 0.58 +3.17 Nov 1, 2021 Jan 31, 2022
Q3 2021 0.95 +5.14 Aug 1, 2021 Oct 31, 2021
Q2 2021 0.39 +4.06 May 1, 2021 Jul 31, 2021
Q1 2021 0.89 +6.87 Feb 1, 2021 Apr 30, 2021
Q4 2020 -2.6 Nov 1, 2020 Jan 31, 2021
Q3 2020 -4.19 Aug 1, 2020 Oct 31, 2020
Q2 2020 -3.67 May 1, 2020 Jul 31, 2020
Q1 2020 -5.98 Feb 1, 2020 Apr 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.